Press release content from Business Wire. The AP news staff was not involved in its creation.
PRESS RELEASE: Paid content from Business Wire
Press release content from Business Wire. The AP news staff was not involved in its creation.

Malaria Clinical Trial Pipeline - Global Forecast to 2024 - ResearchAndMarkets.com

June 7, 2019

DUBLIN--(BUSINESS WIRE)--Jun 7, 2019--

The “Global Malaria Clinical Trial Pipeline Highlights - 2019” report has been added to ResearchAndMarkets.com’s offering.

Malaria Pipeline Highlights - 2019, provides most up-to-date information on key pipeline products in the global Malaria market. It covers emerging therapies for Malaria in active clinical development stages including early and late stage clinical trials. The pipeline data presented in this report helps executives for tracking competition, identifying partners, evaluating opportunities, formulating business development strategies, and executing in-licensing and out-licensing deals.

Clinical Trial Stages:

The report provides Malaria pipeline products by clinical trial stages including both early and late stage development - phase 3 clinical trials, phase 2 clinical trials, phase 1 clinical trials, preclinical research, and discovery stage.

Drug Mechanism Classes:

The report provides Malaria pipeline products by their dominant mechanism of action/drug class. This helps executives categorize products based on their drug class and also assess the strengths and weaknesses of compounds.


The report provides Malaria pipeline products by the company.

Short-term Launch Highlights:

Find out which Malaria pipeline products will be launched in the US and Ex-US till 2024.


Key Topics Covered:

1. Malaria Pipeline by Stages

2. Malaria Phase 3 Clinical Trial Insights

3. Malaria Phase 2 Clinical Trial Insights

4. Malaria Phase 1 Clinical Trial Insights

5. Malaria Preclinical Research Insights

6. Malaria Discovery Stage Insights

7. Appendix

8. Research Methodology

For more information about this report visit https://www.researchandmarkets.com/r/gg5uj9

View source version on businesswire.com:https://www.businesswire.com/news/home/20190607005145/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Press Manager


For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Related Topics:Infectious Diseases Drugs,Clinical Trials



SOURCE: Research and Markets

Copyright Business Wire 2019.

PUB: 06/07/2019 05:38 AM/DISC: 06/07/2019 05:38 AM